Cargando…

Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia

BACKGROUND: Molecular analysis is a promising source of clinically useful prognostic biomarkers. The aim of this investigation was to identify prognostic biomarkers for patients with acute myeloid leukemia (AML) by using the gene expression profile dataset from public database. METHODS: The gene exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Rui, Liao, Xiwen, Li, Qiaochuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679677/ https://www.ncbi.nlm.nih.gov/pubmed/29138577 http://dx.doi.org/10.2147/OTT.S147717

Ejemplares similares

Identification of key pathways and genes in TP53 mutation acute myeloid leukemia: evidence from bioinformatics analysis
por: Huang, Rui, et al.
Publicado: (2017)

Comprehensive investigation of the clinical significance of long non-coding RNA HOXA-AS2 in acute myeloid leukemia using genome-wide RNA sequencing dataset
por: Huang, Rui, et al.
Publicado: (2021)

Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemia
por: Shi, Lingling, et al.
Publicado: (2021)

Identification and Validation of STAT6 as a Prognostic and Predictive Biomarker in Acute Myeloid Leukemia
por: Liu, Wei, et al.
Publicado: (2020)

Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma
por: Liao, Xiwen, et al.
Publicado: (2018)

Identification of potential prognostic small nucleolar RNA biomarkers for predicting overall survival in patients with sarcoma
por: Liu, Jianwei, et al.
Publicado: (2020)

Genome-scale integrated analysis to identify prospective molecular mechanisms and therapeutic targets in isocitrate dehydrogenase 2 R140Q-mutated acute myeloid leukemia
por: Huang, Rui, et al.
Publicado: (2019)

CDK6 Is a Potential Prognostic Biomarker in Acute Myeloid Leukemia
por: Liu, Wei, et al.
Publicado: (2021)

Identification of prognostic genes in the acute myeloid leukemia microenvironment
por: Huang, Shaoxin, et al.
Publicado: (2019)

Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis
por: Zhu, Fangxiao, et al.
Publicado: (2018)

The Solute Carrier Family 2 Genes Are Potential Prognostic Biomarkers in Acute Myeloid Leukemia
por: Lai, Binbin, et al.
Publicado: (2020)

The Prognostic Value of Sarcopenia in Acute Myeloid Leukemia Patients and the Development and Validation of a Novel Nomogram for Predicting Survival
por: Sun, Qian, et al.
Publicado: (2022)

Identification of LPCAT1 expression as a potential prognostic biomarker guiding treatment choice in acute myeloid leukemia
por: Wang, Ke, et al.
Publicado: (2021)

Data mining in acute myeloid leukemia: identification of disease biomarkers, prognostic factors, novel targets, and potential drugs
por: Machado-Neto, João Agostinho, et al.
Publicado: (2023)

Identification of the 7-lncRNA Signature as a Prognostic Biomarker for Acute Myeloid Leukemia
por: Liu, Chun-yu, et al.
Publicado: (2021)

Identification of Circulating MicroRNAs as Potential Biomarkers for Detecting Acute Myeloid Leukemia
por: Zhi, Feng, et al.
Publicado: (2013)

Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia
por: Wang, Jie, et al.
Publicado: (2021)

Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia
por: Zhou, Jing-dong, et al.
Publicado: (2018)

NPM1A in Plasma is a Potential Prognostic Biomarker in Acute Myeloid Leukemia
por: Sun, Chengming, et al.
Publicado: (2018)

Notch Signaling Molecules as Prognostic Biomarkers for Acute Myeloid Leukemia
por: Takam Kamga, Paul, et al.
Publicado: (2019)

Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma
por: Zhou, Meng, et al.
Publicado: (2015)

SPRED1 Is Downregulated and a Prognostic Biomarker in Adult Acute Myeloid Leukemia
por: Zhang, Rui, et al.
Publicado: (2020)

A Prognostic Model of Seven Immune Genes to Predict Overall Survival in Childhood Acute Myeloid Leukemia
por: Luo, Yan, et al.
Publicado: (2022)

MicroRNA-181 as a prognostic biomarker for survival in acute myeloid leukemia: a meta-analysis
por: Guo, Qiang, et al.
Publicado: (2017)

Comprehensive analysis of SPAG1 expression as a prognostic and predictive biomarker in acute myeloid leukemia by integrative bioinformatics and clinical validation
por: Gu, Yu, et al.
Publicado: (2022)

Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia
por: Zhang, Ting-juan, et al.
Publicado: (2021)

BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2
por: Niu, Yuna, et al.
Publicado: (2018)

PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia
por: Cheng, Hui, et al.
Publicado: (2017)

HCK is a Potential Prognostic Biomarker that Correlates with Immune Cell Infiltration in Acute Myeloid Leukemia
por: Cheng, Fang, et al.
Publicado: (2022)

The Identification of APOBEC3G as a Potential Prognostic Biomarker in Acute Myeloid Leukemia and a Possible Drug Target for Crotonoside
por: Ma, Chenchen, et al.
Publicado: (2022)

Identification of immunity-related lncRNAs and construction of a ceRNA network of potential prognostic biomarkers in acute myeloid leukemia
por: Xue, Jia, et al.
Publicado: (2023)

Identification and validation of a 7-genes prognostic signature for adult acute myeloid leukemia based on aging-related genes
por: Ke, Peng, et al.
Publicado: (2023)

Identification of Long Non-Coding RNA SNHG Family as Promising Prognostic Biomarkers in Acute Myeloid Leukemia
por: Shi, Jian, et al.
Publicado: (2020)

Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia
por: Cui, Di, et al.
Publicado: (2022)

SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia
por: Deng, Ailing, et al.
Publicado: (2016)

Survival prediction in acute myeloid leukemia using gene expression profiling
por: Lai, Binbin, et al.
Publicado: (2022)

Research progress on molecular biomarkers of acute myeloid leukemia
por: Yin, Pei-Yuan, et al.
Publicado: (2023)

Identification of survival-related alternative splicing signatures in acute myeloid leukemia
por: Zhang, Biyu, et al.
Publicado: (2021)

Identification and Validation of a Prognostic Risk-Scoring Model Based on Ferroptosis-Associated Cluster in Acute Myeloid Leukemia
por: Wang, Jinghua, et al.
Publicado: (2022)

Validating the knowledge bank approach for personalized prediction of survival in acute myeloid leukemia: a reproducibility study
por: Xu, Yujun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0e9ba86661oabf6tniheanv78l